128
staff
Richard Moscicki
Richard (Rich) A. Moscicki, MD, is the executive vice president for science and regulatory advoca
cy and the chief medical officer at Pharmaceutical Research and Manufacturers of America (PhRMA).
+ Read More
staff
Mohit Joshi
Mohit Joshi is a President of the company.
staff
Lou Maiuri
Lou Maiuri is Chief Operating Officer for State Street Corporation. In this role, he is responsib
le for our IT, Global Delivery, Charles River Development (CRD), State Street Global Exchange and Global Markets organizations.
+ Read More
staff
Madeleine Dassule
report
Envisioning a Trusted System for Health Data Accelerating Medical Research
Technological innovation in the health landscape is occurring rapidly, and much of it would not be
possible without patient data.
+ Read More
report
Future of Work: Insights for 2021 and Beyond
The COVID-19 pandemic has been a double-whammy for inequality: The worst-off have been hit hardest
while economy-wide digitalization has only exacerbated the skills gap.
+ Read More
report
Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for African Americans and Latinos
'Better Brain Health through Equity: Addressing Health and Economic Disparities in Dementia for Afr
ican Americans and Latinos' centers around two overarching themes: (1) Strengthening the infrastructure among health-care, long-term care, and community-b
+ Read More
report
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People ex
periencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes decades.
+ Read More
report
La competitividad de México como socio comercial estratégico
A principios del 2023, las importaciones de bienes mexicanos por parte de Estados Unidos superaron
a las de China, convirtiendo a México en el principal exportador de bienes a EUA por primera vez en la historia comercial moderna.
+ Read More
panel
Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedica
l innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
video
A Conversation on Digitalization and the Future of Asset Management
Thursday, March 4 from 8 am to 9 am PT